These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
993 related articles for article (PubMed ID: 34730247)
1. T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination. Koutsakos M; Lee WS; Wheatley AK; Kent SJ; Juno JA J Leukoc Biol; 2022 Feb; 111(2):355-365. PubMed ID: 34730247 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence. Boppana S; Qin K; Files JK; Russell RM; Stoltz R; Bibollet-Ruche F; Bansal A; Erdmann N; Hahn BH; Goepfert PA PLoS Pathog; 2021 Jul; 17(7):e1009761. PubMed ID: 34270631 [TBL] [Abstract][Full Text] [Related]
3. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
4. High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection. Kawasuji H; Morinaga Y; Nagaoka K; Tani H; Yoshida Y; Yamada H; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Niimi H; Yamamoto Y Front Immunol; 2024; 15():1377014. PubMed ID: 38694512 [TBL] [Abstract][Full Text] [Related]
5. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants. Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349 [TBL] [Abstract][Full Text] [Related]
6. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals. Zhang J; Wu Q; Liu Z; Wang Q; Wu J; Hu Y; Bai T; Xie T; Huang M; Wu T; Peng D; Huang W; Jin K; Niu L; Guo W; Luo D; Lei D; Wu Z; Li G; Huang R; Lin Y; Xie X; He S; Deng Y; Liu J; Li W; Lu Z; Chen H; Zeng T; Luo Q; Li YP; Wang Y; Liu W; Qu X Nat Microbiol; 2021 Jan; 6(1):51-58. PubMed ID: 33199863 [TBL] [Abstract][Full Text] [Related]
7. Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations. Wang J; Li K; Wang Y; Lin Z; Li W; Cao J; Mei X; Wei R; Yang J; Zhai X; Huang D; Zhou K; Liang X; Wang Z mBio; 2024 Oct; 15(10):e0142924. PubMed ID: 39248564 [TBL] [Abstract][Full Text] [Related]
8. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days. Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R Front Immunol; 2021; 12():726960. PubMed ID: 34671348 [TBL] [Abstract][Full Text] [Related]
9. High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells. Chen JS; Chow RD; Song E; Mao T; Israelow B; Kamath K; Bozekowski J; Haynes WA; Filler RB; Menasche BL; Wei J; Alfajaro MM; Song W; Peng L; Carter L; Weinstein JS; Gowthaman U; Chen S; Craft J; Shon JC; Iwasaki A; Wilen CB; Eisenbarth SC Sci Immunol; 2022 Feb; 7(68):eabl5652. PubMed ID: 34914544 [TBL] [Abstract][Full Text] [Related]
11. Follicular Helper T Cells in the Immunopathogenesis of SARS-CoV-2 Infection. Cui D; Tang Y; Jiang Q; Jiang D; Zhang Y; Lv Y; Xu D; Wu J; Xie J; Wen C; Lu L Front Immunol; 2021; 12():731100. PubMed ID: 34603308 [TBL] [Abstract][Full Text] [Related]
12. Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects. Zheng J; Deng Y; Zhao Z; Mao B; Lu M; Lin Y; Huang A Cell Mol Immunol; 2022 Feb; 19(2):150-157. PubMed ID: 34645940 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Human Circulating T Follicular Helper Cells in Influenza- and SARS-CoV-2-Specific B Cell Immunity. Koutsakos M; Kedzierska K; Nguyen THO Methods Mol Biol; 2022; 2380():201-209. PubMed ID: 34802133 [TBL] [Abstract][Full Text] [Related]
14. A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2. Steinbuck MP; Seenappa LM; Jakubowski A; McNeil LK; Haqq CM; DeMuth PC Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33547083 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545 [TBL] [Abstract][Full Text] [Related]
16. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice. de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303 [TBL] [Abstract][Full Text] [Related]
17. The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants. Chen Y; Chen L; Yin S; Tao Y; Zhu L; Tong X; Mao M; Li M; Wan Y; Ni J; Ji X; Dong X; Li J; Huang R; Shen Y; Shen H; Bao C; Wu C Emerg Microbes Infect; 2022 Dec; 11(1):1524-1536. PubMed ID: 35608053 [TBL] [Abstract][Full Text] [Related]
18. Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination. Najimi N; Kadi C; Elmtili N; Seghrouchni F; Bakri Y Hum Antibodies; 2024; 32(3):85-106. PubMed ID: 38758995 [TBL] [Abstract][Full Text] [Related]